Senores Pharmaceuticals Limited (BOM:544319)

Market Cap	33.12B
Revenue (ttm)	4.56B
Net Income (ttm)	675.60M
Shares Out	n/a
EPS (ttm)	17.26
PE Ratio	49.02
Forward PE	30.03
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,333
Average Volume	19,929
Open	695.00
Previous Close	695.75
Day's Range	675.35 - 712.00
52-Week Range	440.00 - 736.80
Beta	n/a
RSI	59.97
Earnings Date	Nov 14, 2025

About Senores Pharmaceuticals

Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. The company offers critical care pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimal...

• Industry: Pharmaceutical Preparations
• Founded: 2017
• Employees: 194
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544319

Financial Performance

In 2024, Senores Pharmaceuticals's revenue was 3.98 billion, an increase of 85.65% compared to the previous year's 2.15 billion. Earnings were 585.60 million, an increase of 86.20%.